List Trials for Newly Diagnosed Pancreatic Cancer

Pancreatic Cancer


PEGPH20 for Stage IV Untreated Pancreatic Cancer (2687)
A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase)Combined With Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic Cancer

Investigator: Sunil R. Hingorani, MD;   Conditions: Metastatic Pancreatic Cancer;    Status: Closed;   Study ID: NCT01839487

FOLFIRINOX w/wo Hyperacute®-Pancreas Immunotherapy for Pancreatic Cancer (8028)
A Phase III Study Of FOLFIRINOX With Or Without Hyperacute®-Pancreas (algenpantucel-L) Immunotherapy In Subjects With Borderline Resectable Or Locally Advanced Unresectable Pancreatic Cancer

Investigator: Andrew Coveler, MD;   Conditions: Pancreatic Cancer;    Status: Recruiting;   Study ID: NCT01836432